Galenical and clinical development of Nagasin®, a multi-strain synbiotic food supplement with strong anti-microbial activity against Clostridioides di

• Forschungsstelle: INNOSUISSE
• Projektnummer: 121.208 IP-LS
• Projekttitel Englisch: Galenical and clinical development of Nagasin®, a multi-strain synbiotic food supplement with strong anti-microbial activity against Clostridioides di

Schlüsselwörter (Englisch)

Life sciences, Foodtech

Abstract (Englisch)

C. difficile leads to severe and recurrent diarrhea that increases mortality, morbidity and healthcare costs. We will develop Nagasin®, an innovative multi-strain symbiotic with strong antimicrobial activity against C. difficile, as food supplement for persons at high risk of C. difficile infection.